• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    HMH Announces Strong Third Quarter 2021 Results; Delivers Billings Growth of 22%; Raises Full Year Guidance Again

    11/4/21 7:00:00 AM ET
    $HMHC
    Service to the Health Industry
    Miscellaneous
    Get the next $HMHC alert in real time by email

    BOSTON, Nov. 4, 2021 /PRNewswire/ -- HMH (NASDAQ:HMHC), a learning technology company, announced strong financial results for the third quarter which ended Sept. 30, 2021.

    Houghton Mifflin Harcourt Logo (PRNewsFoto/Houghton Mifflin Harcourt) (PRNewsfoto/Houghton Mifflin Harcourt)

    "Propelled by strong demand for our comprehensive portfolio of learning solutions, HMH delivered an impressive 22% year-over-year increase in third quarter billings. As a result of the continued momentum across our business, we are raising our full year guidance for the second time this year," said Jack Lynch, President and Chief Executive Officer of HMH. "In just the last two years, we dramatically transformed our business, strengthened our balance sheet and significantly lowered our cost structure to drive incredibly strong free cash flow while successfully executing our digital first, connected strategy—we plan to build on this success."

    "HMH is now among the largest and fastest growing companies in the edtech market. Through execution of our digital first, connected strategy we have grown our connected billings substantially with ARR growing 123% to $120 million or 11% of trailing twelve-month billings," added Lynch.

    Q3 2021 Financial Results and Headlines:





    Three Months Ended September 30,





    Nine Months Ended September 30,



    (in millions of dollars)



    2021 1





    2020 1





    Change





    2021 1





    2020 1





    Change



    Net sales



    $

    417





    $

    331







    25.9

    %



    $

    872





    $

    699







    24.7

    %

    Change in deferred revenue





    130







    119







    9.2

    %





    106







    106







    (0.2)

    %

    Billings 2





    548







    451







    21.5

    %





    978







    806







    21.4

    %

    Impairment charge for goodwill





    —







    —





    NM







    —







    262





    NM



    Income (loss) from continuing operations





    95







    (12)





    NM







    48







    (382)





    NM



    Adjusted EBITDA 3





    146







    83







    76.7

    %





    246







    95





    NM



    Pre-publication or content development costs





    (13)







    (16)







    23.5

    %





    (42)







    (51)







    17.3

    %

    Net cash provided by operating activities





    288







    257







    11.9

    %





    193







    66





    NM



    Free cash flow 3





    265







    230







    15.5

    %





    122







    (20)





    NM





    _______________







    1

    All amounts have been adjusted to eliminate the impact of the HMH Books & Media business which has been removed from   continuing operations and classified as discontinued operations since the first quarter of 2021.   

    2

    An operating measure. Please refer to "Operating Metrics" for an explanation.

    3

    A non-GAAP measure. Please refer to Use of Non-GAAP Financial Measures for an explanation and reconciliation. We are unable to reconcile forward looking unlevered free cash flow without unreasonable efforts.

    NM = not meaningful

    Highlights from the quarter include:

    • Raising FY 2021 billings2 guidance to $1,075-$1,095 million, unlevered free cash flow guidance to 17-19% of billings and Annualized Recurring Revenue (ARR) 2 guidance to 12-15% of billings
    • Strong billings growth across the Company of 22% in Q3 and 21% YTD as demand for teaching and learning solutions continued as students returned to classrooms this fall and teachers further assessed instructional needs for the remainder of the school year
    • ARR2 growth accelerated to 123% bringing ARR to $120 million, or 11% of trailing twelve-month billings. Net Retention Rate (NRR)2 was 153%
    • Trailing twelve-month free cash flow3 of $137 million, an improvement of $36 million compared to the second quarter of 2021, reflecting strong operating leverage and the benefits of 2020 actions to align HMH's cost structure with its digital first, connected strategy
    • Gross leverage ratio of 1.4x, below HMH's target leverage ratio of 2.0x adjusted EBITDA

    Joe Abbott, HMH's Chief Financial Officer said, "Our digital first, connected business exhibits high operating leverage, strong free cash flow and rapidly growing annual recurring revenue which fueled strong third quarter results.  We expect that our transition to digital will continue, leading to a lower variable cost rate and additional opportunities to reduce fixed costs which in turn will lead to increased free cash flow."

    2021 Outlook:

    In light of strong year to date financial results in 2021, the Company is raising its billings, unlevered free cash flow and annualized recurring revenue guidance. Our updated guidance is as follows:

    Estimate



    Outlook for Year ending December

    31, 2021 (Updated on August 5, 2021)



    Outlook for Year ending December 31,

    2021 (Updated on November 4, 2021)

    Total Billings



    $980 to $1,020 million



    $1,075 to $1,095 million

    Unlevered Free Cash Flow



    12-14% of billings



    17-19% of billings

    Annualized Recurring Revenue



    10-15% of billings



    12-15% of billings

    Third Quarter 2021 Financial Results:

    Net Sales: HMH reported net sales of $417 million for the third quarter of 2021, up 26% compared to $331 million in 2020. The increase was primarily due to strong net sales in Extensions, consisting of our Heinemann brand, intervention and supplemental products as well as professional services, which increased by $58 million from $124 million in 2020 to $182 million. Within Extensions, net sales of our Heinemann products increased due to the return of in-person learning for most of our customers, as well as in supplemental and professional services due to strong customer demand. Further, net sales in Core Solutions increased by $28 million from $207 million in 2020 to $235 million, driven by strong open territory net sales as a result of the market recovery.   

    Billings2: Billings for 2021 increased $97 million, or 22%, from 2020. The billings increase was driven by an increase in Extensions, which increased by $82 million as billings of our Heinemann products increased due to the return of in-person learning for most of our customers, as well as in supplemental and professional services due to strong customer demand. Further, Core Solutions increased $15 million, driven by strong open territory billings as a result of the market recovery.

    Cost of Sales: Overall cost of sales increased by $2 million to $183 million in 2021, primarily due to increased sales volume offset partially by lower print costs, increased virtual delivery of products and services along with a favorable inventory obsolescence.

    Selling and Administrative Costs: Selling and administrative costs increased by $17 million in 2021, primarily due to higher variable expenses such as commissions and transportation due to higher billings. Further, there was an increase in incentive compensation compared to the prior year due to higher achievement of performance measures in 2021 compared to 2020.

    Operating Income: Operating income for 2021 was $96 million, a $101 million favorable change from the $6 million operating loss in 2020, primarily due to an increase in net sales of $86 million, along with a $32 million decrease in restructuring/severance and other charges due to the timing of the 2020 restructuring plan.

    Net Income: Net income of $95 million for 2021 was $108 million higher compared to a net loss of $13 million in the same period of 2020. Income from continuing operations for 2021 was $95 million, a $107 million improvement from the $12 million loss from continuing operations in the same period of 2020 due primarily to the same factors impacting operating income. Also, loss from discontinued operations, net of tax, was $1 million in 2020.

    Adjusted EBITDA from continuing operations: Adjusted EBITDA from continuing operations for 2021 was $146 million, a $63 million favorable change from 2020.  

    Nine Months Ended September 30, 2021 Financial Results:

    Net Sales: HMH reported net sales of $872 million for the first nine months of 2021, up 25% compared to $699 million in 2020. The increase was due to strong net sales in Extensions consisting of our Heinemann brand, intervention and supplemental products as well as professional services, which increased by $95 million from $308 million in 2020 to $403 million. Within Extensions, nets sales of our Heinemann products increased due to strong demand across most product portfolios. Further, net sales in Core Solutions increased by $78 million to $469 million, driven by strong open territory net sales as a result of market recovery in 2021.

    Billings2: Billings for 2021 increased $172 million, or 21%, from 2020. The billings increase was driven by an increase in Extensions which increased by $132 million due to strong demand across all product portfolios. Billings of professional services increased due to the recovery of the in-person learning environment. Further, Core Solutions increased $40 million, driven by strong open territory billings as a result of market recovery.

    Cost of Sales: Overall cost of sales increased by $7 million to $423 million in 2021, primarily due to increased sales volume offset partially by lower print costs, increased virtual delivery of products and services and lower amortization expense.

    Selling and Administrative Costs: Selling and administrative costs slightly decreased, primarily due to the 2020 restructuring plan with reduced labor, professional fees and travel and marketing costs. Partially offsetting the aforementioned was an increase in variable expenses such as commissions and transportation due to higher billings along with an increase in incentive compensation.

    Operating Income: Operating income for 2021 was $81 million, a $448 million favorable change from the $367 million operating loss in 2020 primarily due an impairment charge for goodwill in 2020 of $262 million that did not reoccur in 2021. This non-cash impairment was a direct result of the adverse impact that the COVID-19 pandemic had on the Company in 2020. The increase was further driven by an increase in net sales of $173 million and a $22 million favorable change in restructuring/severance and other charges.

    Net Income: Net income of $262 million for 2021 was $659 million higher compared to a net loss of $397 million in the same period of 2020. Income from continuing operations for 2021 was $48 million, a $431 million improvement from the $382 million loss from continuing operations in the same period of 2020 due primarily to the same factors impacting operating income, along with a $13 million non-cash charge for the write off of unamortized deferred financing charges associated with our debt repayment in the second quarter of 2021. Income from discontinued operations, net of tax, also increased $228 million to $214 million from a loss of $14 million in 2020, due to the recognition of the gain on the sale of the HMH Books & Media business of $215 million during 2021.

    Adjusted EBITDA from continuing operations: Adjusted EBITDA from continuing operations for 2021 was $246 million, a $151 million favorable change from $95 million in 2020. 

    Cash Flows and Liquidity: Net cash provided by operating activities for 2021 was $197 million compared to $75 million in 2020. Net cash provided by operating activities from continuing operations was $193 million in 2021, a $127 million increase compared to 2020. The improvement in net cash provided by operating activities from continuing operations resulted from an increase in operating profit, net of non-cash items, of $173 million. The improvement was partially offset by unfavorable changes in net operating assets and liabilities of $46 million. Net cash provided by operating activities included $4 million and $9 million of cash flow from discontinued operations in 2021 and 2020, respectively. HMH's free cash flow from continuing operations, defined as net cash from operating activities minus capital expenditures, favorably changed $142 million from a usage of $20 million in 2020 to cash flow of $122 million in 2021.

    As of Nov. 4, 2021, there were no amounts outstanding under our revolving credit facility. We expect our net cash from operations combined with our cash and cash equivalents and borrowing availability under our revolving credit facility to provide sufficient liquidity to fund our current obligations, capital spending, debt service requirements and working capital requirements over at least the next twelve months.

    Conference Call:

    At 9:30 a.m. ET on Thursday, Nov. 4, 2021, HMH will host a conference call to discuss the results with its investors. The call will be webcast live at ir.hmhco.com. The following information is provided for investors who would like to participate:

    Toll Free: (844) 835-6565

    International: (484) 653-6719

    Passcode: 4666615  

    Moderator: Chris Symanoskie, Vice President, Investor Relations

    Webcast Link: https://edge.media-server.com/mmc/p/ybhqjui4

    An archived webcast with the accompanying slides will be available at ir.hmhco.com for one year for those unable to participate in the live event. An audio replay of this conference call will also be available until November 14, 2021 via the following telephone numbers: (855) 859-2056 in the United States and (404) 537-3406 internationally using passcode 4666615.

    Use of Non-GAAP Financial Measures:

    To supplement our financial statements presented in accordance with Generally Accepted Accounting Principles (GAAP) and to provide additional insights into our performance (for a completed period and/or on a forward-looking basis), we have presented adjusted EBITDA from continuing operations and free cash flow. These measures are not prepared in accordance with GAAP. This information should be considered as supplemental in nature and should not be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. Management believes that the presentation of these non-GAAP measures provides useful information to investors regarding our results of operations and/or our expected results of operations because it assists both investors and management in analyzing and benchmarking the performance and value of our business.

    Management believes that the presentation of adjusted EBITDA provides useful information to our investors and management as an indicator of our performance that is not affected by debt restructurings, fluctuations in interest rates or effective tax rates, gains or losses on investments, non-cash charges and impairment charges, levels of depreciation or amortization, and acquisition/disposition-related activity costs, legal settlement costs, restructuring costs and integration costs. Accordingly, management believes that this measure is useful for comparing our performance from period to period and makes decisions based on it. In addition, targets in adjusted EBITDA (further adjusted to include the change in deferred revenue) are used as performance measures to determine certain incentive compensation of management. Management also believes that the presentation of free cash flow provides useful information to our investors because management regularly reviews these metrics as an important indicator of how much cash is generated by general business operations, excluding capital expenditures, and makes decisions based on it.

    Other companies may define these non-GAAP measures differently and, as a result, our use of these non-GAAP measures may not be directly comparable to adjusted EBITDA and free cash flow used by other companies. Although we use these non-GAAP measures as financial measures to assess our business, the use of non-GAAP measures is limited as they include and/or do not include certain items not included and/or included in the most directly comparable GAAP measure. Adjusted EBITDA should be considered in addition to, and not as a substitute for, net income or loss prepared in accordance with GAAP as a measure of performance; and free cash flow should be considered in addition to, and not as a substitute for, net cash from operating activities prepared in accordance with GAAP. Adjusted EBITDA is not intended to be a measure of liquidity nor is free cash flow intended to be a measure of residual cash flow available for discretionary use. You are cautioned not to place undue reliance on these non-GAAP measures. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures (to the extent available without unreasonable efforts in the case of forward-looking measures) and related disclosure is provided in the appendix to this news release.

    Operating Metrics:

    Annualized Recurring Revenue (ARR) for a given period is the annualized revenues derived from termed subscription contracts existing at the end of the period. ARR excludes contracts that are one-time in nature. ARR is currently one of the key performance metrics being used by management to assess the health and trajectory of our business. ARR does not have a standardized definition and is therefore unlikely to be comparable to similarly titled measures presented by other companies. ARR should be viewed independently of U.S. GAAP revenue, deferred revenue and unbilled revenue and is not intended to be combined with or to replace those items. ARR does not represent revenue for any particular period or remaining revenue that will be recognized in future periods. ARR is not a forecast and the active contracts at the end of a reporting period used in calculating ARR may or may not be extended or renewed by our customers. 

    Billings is an operating measure which we derive from net sales taking into account the change in deferred revenue. Billings for Core Solutions and Extensions is an operating measure based on invoiced sales adjusted for returns, other publishing income and change in deferred revenue.

    Connected Sales are billings from the sale of core, intervention, supplemental, assessment and service offerings hosted on or transitioning to be hosted on our Ed: Your Friend in Learning® teaching and learning platform.

    Gross Leverage Ratio is the total amount of outstanding gross financial debt on a consolidated basis divided by the trailing twelve months Adjusted EBITDA from continuing operations. 

    Net Retention Rate (NRR) is the rate at which existing customers are renewing and expanding. The dollar-based net retention rate is calculated as of a period end by starting with the ARR from all customers as of the 12 months prior to such period end. The ARR is then calculated from these same customers as of the current period end, which includes customer renewals, upsells and expansion and is net of contraction or churn over the trailing 12 months, but excludes revenue from new customers in the current period. The dollar-based net retention rate is calculated by dividing the ARR from these customers as of the current period end by the ARR from these customers as of 12 months prior to such period end.

    About HMH

    Houghton Mifflin Harcourt (NASDAQ:HMHC) is a learning technology company committed to delivering connected solutions that engage learners, empower educators and improve student outcomes. As a leading provider of K–12 core curriculum, supplemental and intervention solutions, and professional learning services, HMH partners with educators and school districts to uncover solutions that unlock students' potential and extend teachers' capabilities. HMH serves more than 50 million students and 3 million educators in 150 countries. For more information, visit www.hmhco.com

    Follow HMH on Twitter, Facebook, Instagram and YouTube.

    Contact

    Investor Relations

    Chris Symanoskie, IRC

    VP, Investor Relations

    410-215-1405

    [email protected]

    Media Relations

    Bianca Olson

    SVP, Corporate Affairs

    617-351-3841

    [email protected]

    Forward-Looking Statements

    The statements contained herein include forward-looking statements, which involve risks and uncertainties. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "projects," "anticipates," "expects," "could," "intends," "may," "will," "should," "forecast," "intend," "plan," "potential," "project," "target" or, in each case, their negative, or other variations or comparable terminology. Forward-looking statements include all statements that are not statements of historical facts, including statements regarding our 2021 outlook, efforts to execute on our digital first, connected strategy, opportunities to reduce costs and our expected cash runway and free cash flow generation. They include statements regarding our intentions, beliefs or current expectations concerning, among other things, the impact of the actions described in this press release; our results of operations; financial condition; liquidity; prospects, growth and strategies; the expected impact of the COVID-19 pandemic; the timing, structure and expected impact of our operational efficiency and cost-reduction initiatives and the estimated savings and amounts expected to be incurred in connection therewith; and potential business decisions. We derive many of our forward-looking statements from our operating budgets and forecasts, which are based upon many detailed assumptions. We caution that it is very difficult to predict the impact of known factors, and, of course, it is impossible for us to anticipate all factors that could affect our actual results. All forward-looking statements are based upon information available to us on the date of this report.

    By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that actual results may differ materially from those made in or suggested by the forward-looking statements contained herein. In addition, even if actual results are consistent with the forward-looking statements contained herein, those results or developments may not be indicative of results or developments in subsequent periods.

    Important factors that could cause actual results to vary from expectations include, but are not limited to: the duration and severity of the COVID-19 pandemic and its impact on the federal, state and local economies and on K–12 schools; any disruption resulting from the completed sale of our HMH Books & Media business that adversely affects our businesses and business relationships, including with employees and suppliers; the rate and state of technological change; state requirements related to digital instructional materials; our ability to execute on our digital first, connected strategy; increases in our operating costs; management and personnel changes; timing, higher costs and unintended consequences of our operational efficiency and cost-reduction initiatives; and other factors discussed in our news releases, public statements and/or filings with the U.S. Securities and Exchange Commission, including our most recent Annual and Quarterly Reports on Form 10-K and Form 10-Q. In light of these risks, uncertainties and assumptions, the forward-looking events described herein may not occur.

    We undertake no obligation, and do not expect, to publicly update or publicly revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. All subsequent written and oral forward-looking statements attributable to us or to persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained herein.

     

    Houghton Mifflin Harcourt Company

    Consolidated Balance Sheets (Unaudited)







    September 30,





    December 31,



    (in thousands of dollars, except share information)



    2021





    2020



    Assets

















    Current assets

















    Cash and cash equivalents



    $

    420,318





    $

    281,200



    Accounts receivable, net





    299,413







    88,830



    Inventories





    96,471







    145,553



    Prepaid expenses and other assets





    26,193







    19,276



    Assets of discontinued operations





    —







    160,053



    Total current assets





    842,395







    694,912





















    Property, plant, and equipment, net





    80,978







    88,801



    Pre-publication costs, net





    163,255







    202,820



    Royalty advances to authors, net





    1,581







    2,425



    Goodwill





    437,977







    437,977



    Other intangible assets, net





    370,047







    402,484



    Operating lease assets





    117,410







    126,850



    Deferred income taxes





    2,415







    2,415



    Deferred commissions





    37,309







    30,659



    Other assets





    32,980







    31,783



    Total assets



    $

    2,086,347





    $

    2,021,126



    Liabilities and Stockholders' Equity

















    Current liabilities

















    Current portion of long-term debt



    $

    —





    $

    19,000



    Accounts payable





    49,736







    38,751



    Royalties payable





    44,766







    34,765



    Salaries, wages, and commissions payable





    61,133







    21,723



    Deferred revenue





    386,431







    342,605



    Interest payable





    4,260







    11,017



    Severance and other charges





    1,283







    19,590



    Accrued pension benefits





    118







    1,593



    Accrued postretirement benefits





    1,555







    1,555



    Operating lease liabilities





    10,506







    9,669



    Other liabilities





    40,273







    22,912



    Liabilities of discontinued operations





    —







    30,662



    Total current liabilities





    600,061







    553,842





















    Long-term debt, net of discount and issuance costs





    317,095







    624,692



    Operating lease liabilities





    131,582







    132,014



    Long-term deferred revenue





    624,953







    562,679



    Accrued pension benefits





    15,021







    24,061



    Accrued postretirement benefits





    15,338







    16,566



    Deferred income taxes





    11,885







    16,411



    Other liabilities





    215







    398



    Total liabilities





    1,716,150







    1,930,663



    Commitments and contingencies

















    Stockholders' equity

















    Preferred stock, $0.01 par value: 20,000,000 shares authorized; no shares issued

    and outstanding at September 30, 2021 and December 31, 2020





    —







    —



    Common stock, $0.01 par value: 380,000,000 shares authorized; 152,257,784 and 150,459,034 shares issued at September 30, 2021 and December 31, 2020, respectively; 127,680,750 and 125,882,000 shares outstanding at September 30, 2021 and December 31, 2020, respectively





    1,523







    1,505



    Treasury stock, 24,577,034 shares as of September 30, 2021 and December 31, 2020, respectively, at cost





    (518,030)







    (518,030)



    Capital in excess of par value





    4,927,934







    4,918,542



    Accumulated deficit





    (3,993,826)







    (4,255,830)



    Accumulated other comprehensive loss





    (47,404)







    (55,724)



    Total stockholders' equity





    370,197







    90,463



    Total liabilities and stockholders' equity



    $

    2,086,347





    $

    2,021,126



     

     

    Houghton Mifflin Harcourt Company

    Consolidated Statements of Operations (Unaudited)







    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,



    (in thousands of dollars, except share and per share information)



    2021





    2020





    2021





    2020



    Net sales



    $

    417,130





    $

    331,205





    $

    871,997





    $

    699,287



    Costs and expenses

































    Cost of sales, excluding publishing rights and pre-publication

       amortization





    152,893







    146,155







    335,390







    310,351



    Publishing rights amortization





    2,516







    3,469







    8,171







    11,332



    Pre-publication amortization





    27,620







    31,570







    79,177







    93,791



    Cost of sales





    183,029







    181,194







    422,738







    415,474



    Selling and administrative





    134,951







    118,275







    338,953







    339,815



    Other intangible assets amortization





    7,241







    5,857







    23,016







    17,568



    Impairment charge for goodwill





    —







    —







    —







    262,000



    Restructuring/severance and other charges





    33







    31,776







    9,880







    31,776



    Gain on sale of assets





    (3,661)







    —







    (3,661)







    —



    Operating income (loss)





    95,537







    (5,897)







    81,071







    (367,346)



    Other income (expense)

































    Retirement benefits non-service income (expense)





    214







    61







    (12)







    183



    Interest expense





    (8,239)







    (9,311)







    (26,788)







    (29,178)



    Interest income





    18







    32







    52







    873



    Change in fair value of derivative instruments





    (368)







    432







    (915)







    172



    Gain on investments





    606







    1,738







    1,442







    1,738



    Income from transition services agreement





    1,399







    —







    2,253







    —



    Loss on extinguishment of debt





    —







    —







    (12,505)







    —



    Income (loss) from continuing operations before taxes





    89,167







    (12,945)







    44,598







    (393,558)



    Income tax benefit for continuing operations





    (6,192)







    (1,060)







    (3,891)







    (11,210)



    Income (loss) from continuing operations





    95,359







    (11,885)







    48,489







    (382,348)



    Loss from discontinued operations, net of tax





    —







    (667)







    (1,005)







    (14,345)



    Gain on sale of discontinued operations, net of tax





    —







    —







    214,520







    —



    (Loss) income from discontinued operations, net of tax





    —







    (667)







    213,515







    (14,345)



    Net income (loss)



    $

    95,359





    $

    (12,552)





    $

    262,004





    $

    (396,693)



    Net income (loss) per share attributable to common stockholders

































    Basic:

































           Continuing operations



    $

    0.75





    $

    (0.09)





    $

    0.38





    $

    (3.05)



           Discontinued operations





    —







    (0.01)







    1.68







    (0.12)



           Net income (loss)



    $

    0.75





    $

    (0.10)





    $

    2.06





    $

    (3.17)



    Diluted:

































           Continuing operations



    $

    0.72





    $

    (0.09)





    $

    0.37





    $

    (3.05)



           Discontinued operations





    —







    (0.01)







    1.64







    (0.12)



           Net income (loss)



    $

    0.72





    $

    (0.10)





    $

    2.01





    $

    (3.17)



    Weighted average shares outstanding

































    Basic





    127,674,513







    125,799,018







    127,220,429







    125,317,284



    Diluted





    131,652,417







    125,799,018







    130,667,785







    125,317,284



     

     

    Houghton Mifflin Harcourt Company

    Consolidated Statements of Cash Flows (Unaudited)







    Nine Months Ended

    September 30,



    (in thousands of dollars)



    2021





    2020



    Cash flows from operating activities

















    Net income (loss)



    $

    262,004





    $

    (396,693)



    Adjustments to reconcile net income (loss) to net cash provided by operating activities

















    Loss from discontinued operations, net of tax





    1,005







    14,345



    Gain on sale of discontinued operations, net of tax





    (214,520)







    —



    Gain on sale of assets





    (3,661)







    —



    Depreciation and amortization expense





    144,698







    160,073



    Operating lease assets, amortization and impairments





    9,411







    9,565



    Amortization of debt discount and deferred financing costs





    2,096







    1,979



    Gain on investments





    (1,442)







    (1,738)



    Deferred income taxes





    (4,526)







    (12,084)



    Stock-based compensation expense





    8,727







    8,295



    Write-off of property, plant, and equipment





    1,606







    —



    Loss on extinguishment of debt





    12,505







    —



    Impairment charge for goodwill





    —







    262,000



    Change in fair value of derivative instruments





    915







    (172)



    Changes in operating assets and liabilities

















    Accounts receivable





    (200,632)







    (106,852)



    Inventories





    49,081







    38,566



    Other assets





    (13,767)







    (10,663)



    Accounts payable and accrued expenses





    53,878







    4,764



    Royalties payable and author advances, net





    12,467







    (21,169)



    Deferred revenue





    106,100







    105,347



    Interest payable





    (6,757)







    155



    Severance and other charges





    (18,307)







    22,494



    Accrued pension and postretirement benefits





    (2,656)







    (5,532)



    Operating lease liabilities





    436







    (7,598)



    Other liabilities





    (5,964)







    935



    Net cash provided by operating activities - continuing operations





    192,697







    66,017



    Net cash provided by operating activities - discontinued operations





    3,880







    9,149



    Net cash provided by operating activities





    196,577







    75,166



    Cash flows from investing activities

















    Additions to pre-publication costs





    (42,104)







    (50,919)



    Additions to property, plant, and equipment





    (28,672)







    (35,275)



    Proceeds from sale of business





    349,000







    —



    Proceeds from sale of assets





    5,000







    —



    Net cash provided by (used in) investing activities - continuing operations





    283,224







    (86,194)



    Net cash used in investing activities - discontinued operations





    (647)







    (402)



    Net cash provided by (used in) investing activities





    282,577







    (86,596)



    Cash flows from financing activities

















    Borrowings under revolving credit facility





    —







    150,000



    Payments of revolving credit facility





    —







    (150,000)



    Payments of long-term debt





    (342,031)







    (14,250)



    Tax withholding payments related to net share settlements of restricted stock units





    —







    (48)



    Issuance of common stock under employee stock purchase plan





    410







    918



    Net collections under transition services agreement





    1,585







    —



    Net cash used in financing activities - continuing operations





    (340,036)







    (13,380)



    Net increase (decrease) in cash and cash equivalents





    139,118







    (24,810)



    Cash and cash equivalents at beginning of the period





    281,200







    296,353



    Cash and cash equivalents at end of the period



    $

    420,318





    $

    271,543



     

     

    Houghton Mifflin Harcourt Company

    Non-GAAP Reconciliations (Unaudited)



    Adjusted EBITDA 1 



    (in thousands of dollars)







    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,







    2021





    2020





    2021





    2020



    Net income (loss) from continuing operations



    $

    95,359





    $

    (11,885)





    $

    48,489





    $

    (382,348)



    Interest expense





    8,239







    9,311







    26,788







    29,178



    Interest income





    (18)







    (32)







    (52)







    (873)



    Provision (benefit) for income taxes





    (6,192)







    (1,060)







    (3,891)







    (11,210)



    Depreciation expense





    11,063







    12,358







    34,334







    37,382



    Amortization expense





    37,377







    40,896







    110,364







    122,691



    Non-cash charges – goodwill impairment





    —







    —







    —







    262,000



    Non-cash charges – stock compensation





    3,177







    2,971







    8,727







    8,295



    Non-cash charges – (gain) loss on derivative instruments





    368







    (432)







    915







    (172)



    Fees, expenses or charges for equity offerings, debt or

       acquisitions/dispositions





    676







    339







    866







    366



    Gain on investments





    (606)







    (1,738)







    (1,442)







    (1,738)



    Gain on sale of assets





    (3,661)







    —







    (3,661)







    —



    Loss on debt extinguishment





    —







    —







    12,505







    —



    Legal settlement





    —







    —







    2,470







    —



    Restructuring/severance and other charges





    33







    31,776







    9,880







    31,776



    Adjusted EBITDA from continuing operations



    $

    145,815





    $

    82,504





    $

    246,292





    $

    95,347



     

     

    Free Cash Flow 1



    (in thousands of dollars)







    Three Months Ended September 30,





    Nine Months Ended September 30,







    2021





    2020





    2021





    2020



    Cash flows from operating activities

































    Net cash provided by operating activities



    $

    287,630





    $

    257,084





    $

    192,697





    $

    66,017



    Cash flows from investing activities

































    Additions to pre-publication costs





    (12,563)







    (16,423)







    (42,104)







    (50,919)



    Additions to property, plant, and equipment





    (9,614)







    (10,917)







    (28,672)







    (35,275)



    Free Cash Flow



    $

    265,453





    $

    229,744





    $

    121,921





    $

    (20,177)



     













    Trailing Twelve Months Ended

    September 30, 2021







    Cash flows from operating activities















    Net cash provided by operating activities





    $

    233,165







    Cash flows from investing activities















    Additions to pre-publication costs







    (52,057)







    Additions to property, plant, and equipment                







    (44,337)







    Free Cash Flow





    $

    136,771









    1

    All amounts have been adjusted to eliminate the impact of the HMH Books & Media business which has been removed from continuing operations and classified as discontinued operations.

     

    We are unable to reconcile forward looking free cash flow (both before and after interest payments) and related margin without unreasonable efforts. Unlevered free cash flow margin is the ratio of free cash flow before interest payments to billings.

     

    Houghton Mifflin Harcourt Company

    Calculation of Billings and Gross Leverage Ratio (Unaudited)



    Billings 1



    (in thousands of dollars)







    Three Months Ended

    September 30,





    Nine Months Ended

    September 30,







    2021





    2020





    2021





    2020



    Net sales



    $

    417,130





    $

    331,205





    $

    871,997





    $

    699,287



    Change in deferred revenue





    130,419







    119,426







    106,100







    106,347



    Billings



    $

    547,549





    $

    450,631





    $

    978,097





    $

    805,634



     













    Trailing Twelve Months Ended

    September 30, 2021







    Net sales





    $

    1,013,164







    Change in deferred revenue                







    57,931







    Billings





    $

    1,071,095



    Billings is an operating measure utilized by the Company derived as shown above.

     

     

    Gross Leverage Ratio 1









    (in thousands of dollars)



















    September 30,

    2021







    Gross debt



    $

    324,969







    Trailing twelve months Adjusted EBITDA                      



    $

    239,610







    Gross leverage ratio





    1.4

     

     



    Trailing Twelve Months Ended

    September 30, 2021



    Net loss from continuing operations



    $

    (39,853)



    Interest expense





    35,541



    Interest income



    (78)



    Provision (benefit) for income taxes



    (5,138)



    Depreciation expense





    46,826



    Amortization expense





    152,228



    Non-cash charges – goodwill impairment





    17,000



    Non-cash charges – stock compensation





    11,592



    Non-cash charges – (gain) loss on derivative instruments



    415



    Fees, expenses or charges for equity offerings, debt or

    acquisitions/dispositions





    1,580



    Gain on investments



    (1,795)



    Gain on sale of assets





    (3,661)



    Loss on debt extinguishment



    12,505



    Legal settlement





    2,470



    Restructuring/severance and other charges



    9,978



    Adjusted EBITDA from continuing operations



    $

    239,610









    Gross leverage ratio is an operating measure utilized by the Company derived as shown above.





    1

    All amounts have been adjusted to eliminate the impact of the HMH Books & Media business which has been removed from continuing operations and classified as discontinued operations.

     

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hmh-announces-strong-third-quarter-2021-results-delivers-billings-growth-of-22-raises-full-year-guidance-again-301415932.html

    SOURCE Houghton Mifflin Harcourt

    Get the next $HMHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HMHC

    DatePrice TargetRatingAnalyst
    2/25/2022$20.00 → $21.00Outperform → Market Perform
    BMO Capital
    2/24/2022$19.00Outperform → Market Perform
    BMO Capital Markets
    1/11/2022$19.00 → $20.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $HMHC
    SEC Filings

    See more
    • SEC Form 15-12B filed by Houghton Mifflin Harcourt Company

      15-12B - Houghton Mifflin Harcourt Co (0001580156) (Filer)

      4/21/22 2:30:59 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form EFFECT filed by Houghton Mifflin Harcourt Company

      EFFECT - Houghton Mifflin Harcourt Co (0001580156) (Filer)

      4/15/22 12:15:16 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form POS AM filed by Houghton Mifflin Harcourt Company

      POS AM - Houghton Mifflin Harcourt Co (0001580156) (Filer)

      4/12/22 9:28:30 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HMH Unveils Major Platform Enhancements to Empower Educators and Engage Students Heading Back-to-School Nationwide

      Integrations with Google Classroom and Clever, new Spanish-language resources, personalized professional development and more provide streamlined experience, support positive outcomes BOSTON, Aug. 30, 2022 /PRNewswire/ -- Aug. 30, 2022 – As students and teachers nationwide head back to school, learning technology company HMH today announced major enhancements to Ed, HMH's connected teaching and learning platform, that will offer an even more streamlined experience to empower educators and engage students. Seamless integrations with Google Classroom and Clever, as well as refinements and new features to many of HMH's core, supplemental and intervention solutions and professional learning serv

      8/30/22 12:00:00 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • New Research Shows Declining Confidence in the Education Profession, With Educators Calling for Connection, Community and Customization

      Critical insights reveal how edtech is transforming the classroom; 81% of educators say we are now closer to fully realizing the potential of technology in teaching BOSTON, Aug. 18, 2022 /PRNewswire/ -- According to the 2022 Educator Confidence Report, released today from learning technology company HMH, confidence in the education profession has dropped for the second year in a row. An annual barometer for how educators across the country are feeling about the state of teaching and learning, today's report found more than 3 in 4 (76%) educators feel negatively about the state of the teaching profession in the U.S. The Educator Confidence Index, a measure of overall confidence (out of 100),

      8/18/22 10:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • HMH Introduces Connected Foundational Skills Solution Combining Explicit Phonics Instruction and 1:1 AI-driven Tutoring

      HMH's connected teaching and learning approach brings together best of all worlds with Amira Learning + Saxon Phonics & Spelling, providing research-backed foundational reading support for youngest learners BOSTON, Aug. 4, 2022 /PRNewswire/ -- Learning technology company HMH today announced a new connected teaching and learning solution featuring Amira Learning® + Saxon Phonics & Spelling®, to support foundational literacy in K-2 classrooms. Rooted in science of reading research and backed by ESSA-strong evidence bases, this joint solution is designed to complement a comprehensive language arts program with a dynamic mix of print and digital resources that connect explicit, systematic phonic

      8/4/22 9:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Houghton Mifflin Harcourt Company

      SC 13G - Houghton Mifflin Harcourt Co (0001580156) (Subject)

      4/18/22 5:18:22 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13G/A filed by Houghton Mifflin Harcourt Company (Amendment)

      SC 13G/A - Houghton Mifflin Harcourt Co (0001580156) (Subject)

      4/11/22 8:51:33 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form SC 13G/A filed by Houghton Mifflin Harcourt Company (Amendment)

      SC 13G/A - Houghton Mifflin Harcourt Co (0001580156) (Subject)

      2/14/22 2:56:32 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Financials

    Live finance-specific insights

    See more
    • Significant Shareholder Prasad Phatak Sends Letter to Houghton Mifflin Harcourt Company Board of Directors Opposing Veritas Capital Transaction

      Believes Proposed Veritas Tender Offer Significantly Undervalues Company and Deprives Shareholders of Potential Upside under HMHC's Highly Experienced Management Team Does Not Intend to Tender Shares and Urges HMHC to Alternative Options Including Remaining Standalone Public Company Prasad Phatak, a significant shareholder of Houghton Mifflin Harcourt Company ("Houghton Mifflin" or the "Company") (NASDAQ:HMHC) today issued the following letter to the Company's Board of Directors (the "Board"). March 7, 2022 Board of Directors Houghton Mifflin c/o Corporate Secretary 125 High Street Boston, MA 02110 Dear Board Members, I am a shareholder of Houghton Mifflin Harcourt Company ("Houghton

      3/7/22 8:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • Laughing Water Capital Issues Public Letter to Board and Employees of Houghton Mifflin Harcourt

      Believes Veritas Capital's $21 per Share Offer Price Significantly Undervalues the Company and Questions the Timing of the Proposed Transaction Announces Intention Not to Tender its Shares and Encourages Employees to Review the Facts Before Making a Decision ROCKVILLE CENTRE, N.Y., March 01, 2022 (GLOBE NEWSWIRE) -- Laughing Water Capital, LP (together with its affiliates, "LWC"), a value focused investment firm that specializes in businesses undergoing transformational change, today issued a letter to the Board of Directors and employees of Houghton Mifflin Harcourt Company (NASDAQ:HMHC) (the "Company"). In the letter, LWC explains why it will NOT be tendering its shares into Veritas Ca

      3/1/22 8:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • HMH Announces Fourth Quarter and Full Year 2021 Results

      BOSTON, Feb. 24, 2022 /PRNewswire/ -- HMH (NASDAQ:HMHC), a learning technology company, announced financial results for the fourth quarter and full year ended December 31, 2021. Q4 and Full Year 2021 Financial Results: Three Months Ended December 31, Years Ended December 31, (in millions of dollars) 2021 1 2020 1 Change 2021 1 2020 1 Change Net sales $ 179 $ 141 26.7 % $ 1,051 $ 840 25.0 % Change in deferred revenue (47) (48) (3.0) % 59 58 2.1 % Billings 2 132 93 42.0 % 1,110 899 23.5 % Impairment charge for goodwill — 17 NM — 279 NM (Loss) income from continuing operations (4

      2/24/22 7:00:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Houghton Mifflin Harcourt downgraded by BMO Capital with a new price target

      BMO Capital downgraded Houghton Mifflin Harcourt from Outperform to Market Perform and set a new price target of $21.00 from $20.00 previously

      2/25/22 6:08:19 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • Houghton Mifflin Harcourt downgraded by BMO Capital Markets with a new price target

      BMO Capital Markets downgraded Houghton Mifflin Harcourt from Outperform to Market Perform and set a new price target of $19.00

      2/24/22 9:46:25 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • Houghton Mifflin Harcourt upgraded by BMO Capital Markets with a new price target

      BMO Capital Markets upgraded Houghton Mifflin Harcourt from Market Perform to Outperform and set a new price target of $20.00 from $19.00 previously

      1/11/22 7:24:59 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Leadership Updates

    Live Leadership Updates

    See more
    • HMH Appoints Benita Flucker as Chief Equity and Inclusion Officer

      Flucker will focus on equity in curriculum, solutions and services and serve as strategic advisor for HMH employee resource groups BOSTON, July 26, 2022 /PRNewswire/ -- Learning technology company HMH today announced the appointment of Benita Flucker as Chief Equity and Inclusion Officer. In this critical new position, Flucker will oversee HMH's multifaceted commitment to building and delivering curriculum solutions and services that foster a holistic understanding of the world and honor the diverse students, educators and communities HMH serves each day. Working closely with HMH's Chief People Officer Alejandro Reyes, who will continue to lead HMH's employee-focused diversity, equity and in

      7/26/22 11:30:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • ICLE Appoints Dr. Joshua P. Starr as Managing Partner, Concludes Successful Gathering of Thousands of Educators at 30th Annual Model Schools Conference

      REXFORD, N.Y., July 21, 2022 /PRNewswire/ -- The International Center for Leadership in Education (ICLE), a division of learning technology company HMH, today announced that celebrated education leader Dr. Joshua P. Starr has been appointed as Managing Partner. ICLE, one of the nation's leading education consultancies, researches and disseminates best practices for district-wide achievement and is known for its high-impact work around school transformation. In this critical leadership role, Dr. Starr will oversee the organization's strategic direction, working hand-in-hand with ICLE's partners, consultants and fellows in service of creating impactful change and growth for students and teache

      7/21/22 3:12:00 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • Houghton Mifflin Harcourt Appoints Chris Symanoskie as Vice President of Investor Relations

      BOSTON, July 20, 2021 /PRNewswire/ -- Learning technology company Houghton Mifflin Harcourt (HMH) (NASDAQ:HMHC) announced that Chris Symanoskie, IRC has joined the company as Vice President, Investor Relations. In this role, he will serve as the primary liaison between HMH and the financial community and report directly to Chief Financial Officer Joe Abbott. Symanoskie brings over 20 years of investor relations experience with an extensive background in the education services sector. Prior to joining HMH, he served as Vice President of Investor Relations and Corporate Communic

      7/20/21 9:15:00 AM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous

    $HMHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Mckernan John R Jr returned 30,429 shares to the company, closing all direct ownership in the company

      4 - Houghton Mifflin Harcourt Co (0001580156) (Issuer)

      4/11/22 6:07:02 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form 4: Oneill James P. returned 132,921 shares to the company, closing all direct ownership in the company to satisfy withholding obligation

      4 - Houghton Mifflin Harcourt Co (0001580156) (Issuer)

      4/11/22 6:05:24 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous
    • SEC Form 4: Greenthal Jill A returned 60,053 shares to the company, closing all direct ownership in the company

      4 - Houghton Mifflin Harcourt Co (0001580156) (Issuer)

      4/11/22 6:05:04 PM ET
      $HMHC
      Service to the Health Industry
      Miscellaneous